
Innorna Receives IND Clearance by FDA Enabling Phase I Initiation for Herpes Zoster mRNA Vaccine
Innorna focuses on developing best-in-class LNP delivery technology and advancing innovative RNA therapies to address unmet medical needs globally. UNITED STATES, October 3, 2023 /EINPresswire.com/ -- Innorna, a clinical-stage biotech company pioneering …